Cutler Group LP Invitae Corp Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$0.42 - $0.72 $2 - $4	-6 Reduced 6.0%	94 $0
Q2 2023 Jul 18, 2023	SELL	$1.05 - $1.63 $249 - $387	-238 Reduced 70.41%	100 $0
Q1 2023 May 01, 2023	SELL	$1.2 - $2.73 $10,700 - $24,343	-8,917 Reduced 96.35%	338 $0
Q4 2022 Feb 07, 2023	SELL	$1.71 - $3.61 $19,295 - $40,735	-11,284 Reduced 54.94%	9,255 $17,000
Q3 2022 Oct 25, 2022	BUY	$1.9 - $8.63 $39,024 - $177,251	20,539 New	20,539 $50,000
Q1 2022 Apr 14, 2022	SELL	$6.28 - $15.59 $198,680 - $493,220	-31,637 Reduced 59.47%	21,565 $171,000
Q4 2021 Jan 18, 2022	BUY	$14.7 - $28.67 $478,764 - $933,753	32,569 Added 157.85%	53,202 $812,000
Q3 2021 Oct 26, 2021	BUY	$24.31 - $33.6 $297,481 - $411,163	12,237 Added 145.75%	20,633 $586,000
Q2 2021 Jul 19, 2021	SELL	$26.09 - $40.4 $313,445 - $485,365	-12,014 Reduced 58.86%	8,396 $283,000
Q1 2021 Apr 26, 2021	BUY	$33.06 - $56.93 $674,754 - $1.16 Million	20,410 New	20,410 $779,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.